Home > Our Services > Regulatory > eCTD Software Platform for eCTD Submissions

Regulatory: Pharma

eCTD Software Platform for eCTD Submissions

Our services: software support

As part of our regulatory services in pharma, the Alira Health team can publish documents, validate, and compile submissions and submit them via electronic submissions gateway to the FDA.

Why choose Alira Health?

As your partner, Alira Health supports your innovation, optimizing product development success every step of the way. Our integrated, collaborative teams provide a lifecycle approach to delivering our services, including:

Regulatory strategy
Regulatory intelligence
Regulatory operations
Clinical
Market access

Explore Regulatory Pharma Services:

Regulatory Strategy and Due Diligence

FDA Meeting Preparation and Representation

FDA Applications Preparation, Management, and Submissions

CMC, Non-clinical, Clinical, and PK Program Support

Assistance with Accelerated Review Programs

CMC Quality and Regulatory Affairs

Related news

Events July 20, 2021

Webinar Recap: Risk Management & Regulatory Submissions

Download Alira Health's Senior Vice President, Regulatory Affairs, Mary McNamara-Cullinane's webinar presentation, How to Implement Risk Management into Regulatory Submissions Using(...)

Publications July 20, 2021

The Pre-IND to Market Approval Roadmap in the U.S.

Download our latest infographic, The Pre-IND to Market Approval Roadmap in the U.S.

Multimedia April 29, 2021

Alira Health Webinar Replay: Trends and Challenges in US and EU Combination Product Landscapes

Rewatch this timely webinar with Alira Health’s Regulatory leadership team featuring key insights and advice for U.S. and EU companies as they map out their own regulatory pathways(...)

News February 2, 2021

We Secured Breakthrough Device Designation from FDA on PEDRA Xauron Perfusion System

We are proud to announce the firm’s Regulatory practice has secured a Breakthrough Device Designation from FDA for the real-time tissue perfusion system, PEDRA Xauron Perfusion System.

Clinical Regulatory

News January 7, 2021

Alira Health Adds CMC Services through Acquisition of Chamow & Associates

We have acquired Chamow & Associates (www.chamowassociates.com), a California-based integrated CMC advisory firm. This acquisition brings expertise in biologics manufacturing, quality(...)

Advanced Analytics Regulatory Research & Development

News November 20, 2020

Alira Health’s Ventures Portfolio Company, X-COR Therapeutics, Closes Initial $2.6M Funding Round

Alira Health congratulates X-COR Therapeutics for closing a $2.6M seed financing to continue developing its novel extracorporeal carbon dioxide removal device toward clinical trials.(...)

Publications November 1, 2020

Reduce Time to Market with Pre-IND Meetings

Did you know reducing time to market is one of the biggest challenges companies face when seeking FDA approval on their drug development plans and clinical trials?